Gerard Suris - Publications

Predictors of Steroid Failure and Outcomes of Rescue Therapy in Severe ICI-Induced Colitis: A Multicenter Study from GETECCU.

Journal: Digestive diseases and sciences

Published: January 05, 2026

Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.

Journal: Therapeutic advances in gastroenterology

Published: October 14, 2025

Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis.

Journal: Journal of clinical medicine

Published: September 24, 2025

Clostridioides difficile infection: Position paper of the Catalan Society of Gastroenterology.

Journal: Gastroenterologia y hepatologia

Published: August 06, 2025

Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 07, 2024

Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU.

Journal: Therapeutic advances in gastroenterology

Published: November 16, 2023

Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.

Journal: Therapeutic advances in gastroenterology

Published: June 19, 2023

Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopy.

Journal: Gastroenterologia y hepatologia

Published: March 15, 2023

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).

Journal: Journal of clinical medicine

Published: September 18, 2022

Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.

Journal: Journal of Crohn's & colitis

Published: July 27, 2022

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU.

Journal: The American journal of gastroenterology

Published: July 11, 2022

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.

Journal: Journal of clinical medicine

Published: December 09, 2021